WebSep 15, 2024 · The most common side effects of Cisplatin include: nausea, vomiting (may be severe), diarrhea, temporary hair loss, loss in ability to taste food, hiccups, dry mouth, dark urine, decreased sweating, dry skin, and other signs of dehydration Tell the doctor if you have any side effect that bothers you or that does not go away. WebApr 12, 2024 · In animal models, the deletion of Oct1 and Oct2 genes alters the urinary cisplatin excretion without affecting its plasma levels. Furthermore, carrier patients of the Oct2 polymorphism seem to have a lower risk of developing cisplatin nephrotoxicity . AKI, present in 20–30% of patients’ cisplatin exposed, is usually non-oliguric.
Cisplatin Uses, Side Effects & Warnings - Drugs.com
WebCisplatin is also sometimes used to treat head and neck cancer (including cancer of the mouth, lip, cheek, tongue, palate, throat, tonsils, and sinuses), lung cancer, cancer of the … WebOct 4, 2024 · Most sources consider that mothers receiving antineoplastic therapy should not breastfeed, especially with alkylating agents such as cisplatin. [1] Excretion of … canon eos 850d handleiding
Staying Hydrated After Moderate to High-Dose Cisplatin
WebJul 22, 2009 · At 24 hours after cisplatin administration, a cumulative urinary excretion amounting to 45% of the administered dose was observed in Oct1/2 (−/−) mice compared to 91% in wildtype animals ( P = 0.0008), and only 56% of the dose was recovered in Oct1/2 (−/−) mice ( P = 0.0016) ( Figure 2A) within the sample collection period. WebJun 1, 2024 · The recommended dosage of Gemcitabine for injection is 1250 mg/m 2 intravenously over 30 minutes on Days 1 and 8 of each 21-day cycle in combination with cisplatin 100 mg/m 2 administered intravenously on Day 1 after Gemcitabine for injection administration. Refer to cisplatin prescribing information for additional information. … WebFeb 17, 2024 · Cisplatin can cause dose-related peripheral neuropathy that becomes more severe with repeated courses of the drug. Dosage Forms Excipient information presented when available (limited, particularly for generics); consult specific product labeling. Solution, Intravenous [preservative free]: flag pole weight anchors